Cargando…
Peroxiredoxin 1 silencing inhibited the growth and promoted apoptosis of pancreatic cancer cells via targeting FOXO3 gene
OBJECTIVE: Our study aimed to investigate the interaction between peroxiredoxin 1 (Prx1) and forkhead box O3 (FOXO3) and to explore the role of PI3K/AKT pathway in the development of pancreatic cancer. MATERIAL AND METHODS: Human pancreatic normal cells HPDE6-C7 and pancreatic cancer cells PANC-1 we...
Autores principales: | Sun, Xianchun, Kong, Lingting, Li, Bingshu, Zhang, Yan, Yang, Haiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208491/ https://www.ncbi.nlm.nih.gov/pubmed/30464602 http://dx.doi.org/10.2147/CMAR.S177243 |
Ejemplares similares
-
Silencing of Peroxiredoxin 1 Inhibits the Proliferation of Esophageal Cancer Cells and Promotes Apoptosis by Inhibiting the Activity of the PI3K/AKT Pathway
por: Song, Yingjian, et al.
Publicado: (2019) -
Pdcd2l Promotes Palmitate-Induced Pancreatic Beta-Cell Apoptosis as a FoxO1 Target Gene
por: Yin, Ye, et al.
Publicado: (2016) -
Silencing of peroxiredoxin II by promoter methylation is necessary for the survival and migration of gastric cancer cells
por: Hong, Soo Hyun, et al.
Publicado: (2018) -
Up-regulation of peroxiredoxin-1 promotes cell proliferation and metastasis and inhibits apoptosis in cervical cancer
por: Lu, Ermei, et al.
Publicado: (2020) -
CIDEC silencing attenuates diabetic nephropathy via inhibiting apoptosis and promoting autophagy
por: Zheng, Gao‐shu, et al.
Publicado: (2021)